The subjects take dorzolamide hydrochloride / timolol maleate fixed-dose combination eye drop twice a day for 12weeks.The subjects are scheduled to visit a hospital after 4 and 12 weeks and recieve in
Sponsors
Hospital, University of the Ryukyus
Conditions
Glaucomaprimary open angle glaucoma and ocular hypertension
Unknown Phase
Evaluation of dorzolamide/timolol fixed-dose combination therapy for the patients who need more IOP (trough & peak) reduction under treatment of PG analogues
Active, not recruitingJPRN-UMIN000006828
Start: 2011-03-01Target: 40Updated: 2026-06-29
Evaluation of dorzolamide/timolol fixed-dose combination therapy for the patients who need more IOP (trough & peak) reduction under treatment of PG analogues and beta-blocker
Active, not recruitingJPRN-UMIN000006829
Start: 2011-03-01Target: 20Updated: 2026-06-29
Evaluation of dorzolamide/timolol fixed-dose combination therapy for the patients who need more IOP (trough & peak) reduction under treatment of PG analogues, beta-blocker and CAI
Active, not recruitingJPRN-UMIN000006831
Start: 2011-03-01Target: 20Updated: 2026-06-29
Evaluation of dorzolamide/timolol fixed-dose combination therapy for the patients who need more IOP (trough & peak) reduction under treatment of PG analogues and CAI
Active, not recruitingJPRN-UMIN000006830
Start: 2011-03-01Target: 20Updated: 2026-06-29